Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
biochemistry, genetics and molecular biology
Accelerating measles and rubella elimination through research and innovation – Findings from the Measles & Rubella Initiative research prioritization process, 2016
Vaccine, Volume 37, No. 38, Year 2019
Notification
URL copied to clipboard!
Description
The Measles & Rubella Initiative (M&RI) identified five key strategies to achieve measles and rubella elimination, including research and innovation to support cost-effective operations and improve vaccination and diagnostic tools. In 2016, the M&RI Research and Innovation Working Group (R&IWG) completed a research prioritization process to identify key research questions and update the global research agenda. The R&IWG reviewed meeting reports and strategic planning documents and solicited programmatic inputs from vaccination experts at the program operational level through a web survey, to identify previous research priorities and new research questions. The R&IWG then convened a meeting of experts to prioritize the identified research questions in four strategic areas: (1) epidemiology and economics, (2) surveillance and laboratory, (3) immunization strategies, and (4) demand creation and communications. The experts identified 19 priority research questions in the four strategic areas to address key areas of work necessary to further progress toward elimination. Future commitments from partners will be needed to develop a platform for improved coordination with adequate and predictable resources for research implementation and innovation to address these identified priorities. © 2019
Authors & Co-Authors
Grant, Gavin B.
United States, Atlanta
Centers for Disease Control and Prevention
Masresha, Balcha Girma
Congo, Brazzaville
World Health Organization Regional Office for Africa Congo
Moss, William John
United States, Baltimore
Johns Hopkins University
Mulders, Mick Norman
Switzerland, Geneva
Organisation Mondiale de la Santé
Rota, Paul A.
United States, Atlanta
Centers for Disease Control and Prevention
Omer, Saad B.
United States, Atlanta
Emory University
Shefer, Abigail M.
United States, Atlanta
Centers for Disease Control and Prevention
Kriss, Jennifer Lara
United States, Atlanta
Centers for Disease Control and Prevention
Durrheim, David N.
Australia, Callaghan
The University of Newcastle, Australia
Linkins, Robert W.
United States, Atlanta
Centers for Disease Control and Prevention
Goodson, James L.
United States, Atlanta
Centers for Disease Control and Prevention
Statistics
Citations: 11
Authors: 11
Affiliations: 6
Identifiers
Doi:
10.1016/j.vaccine.2019.01.081
ISSN:
0264410X
Research Areas
Infectious Diseases
Maternal And Child Health
Study Design
Cross Sectional Study
Study Approach
Quantitative